Consequently, curcumin represents a promising epigenetic therapeutic agent with the potential to reverse aberrant DNA methylation and gene silencing, as illustrated in Figures 3, 4
Anwar S, Alrumaihi F, Sarwar T et al (2024) Exploring therapeutic potential of catalase: strategies in disease prevention and management
Research suggests BPC-157 has a favorable safety profile in clinical studies, though individual responses may vary
Clinical Evidence: Several studies support anecdotal evidence for the potential of BPC-157 in strengthening the immune system: a) A study published in the Journal of Pharmacological Sciences demonstrated that BPC-157 administration improved immune response and reduced inflammation in animal models, suggesting its immunomodulatory effects
doi: 10.3389/fnut.2023.1068343 Received 12 October 2022 Accepted 21 March 2023 Published 05 April 2023 Volume 10 - 2023 Edited by Andrew Scholey, Monash University, Australia Reviewed by Jessica Zuiga-Hernandez, University of Talca, Chile
